默克和第一三共于周五表示，已自愿撤回其寻求加速批准实验性肺癌疗法的美国申请。
Merck and Daiichi Sankyo have voluntarily withdrawn their US application seeking accelerated approval for their experimental lung cancer therapy, the companies said on Friday.
路透社
默克与第一三共撤回肺癌疗法的美国申请Merck, Daiichi Sankyo withdraw US application for lung cancer therapy
点「原文对照」整页切到原文，或双击某段只看那段的原文。